All In Biotech

Drug Trial Radar · NCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder

Last checked: Nov 19, 2026Latest source record: Sep 7, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 965 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

965

Actual

Start

Jun 2011

Primary completion

Apr 2015

Study completion Apr 2015

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
May 23, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, placebo-controlled, flexible-dose, parallel-group study designed to evaluate the efficacy and safety of lurasidone (in combination with lithium or divalproex) for the maintenance treatment of bipolar I disorder in subjects with or without rapid cycling and /or psychotic features.

Conditions

  • Bipolar I Disorder

Interventions

  • LurasidoneDrug

    Lurasidone 20 mg daily (days 1-3), Lurasidone 40 mg daily (days 4-7), Lurasidone 20-80 mg daily (flexible dose) thereafter

  • PlaceboDrug

    20-80 mg flexible dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Recurrence of Mood Event During the Double Blind Treatment PhaseTime frame: 28 weeks (up to 33 weeks)

Locations

105 sites in 14 countries. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research

    Dothan, Alabama

  • Behavioral Research Specialists, LLC

    Glendale, California

  • AXIS Clinical Trials

    Los Angeles, California

  • Excell Research, Inc.

    Oceanside, California

  • Stanford University School of Medicine Research Program VA Palo Alto Health Care System

    Palo Alto, California

  • SF-CARE, Inc.

    San Francisco, California

  • Neuropsychiatric Research Center of Orange County

    Santa Ana, California

  • "Stanford University School of Medicine

    Stanford, California

  • Florida Clinical Research LLC

    Bradenton, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Galiz Research

    Miami Springs, Florida

  • Clinical Neuroscience Solutions

    Orlando, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Clinco

    Terre Haute, Indiana

  • ActivMed Practices & Research Inc.

    Haverhill, Massachusetts

  • Psych Care Consultants Research

    St Louis, Missouri

  • Village Clinical Research Inc,

    New York, New York

  • Finger Lakes Clinical Research

    Rochester, New York

  • Charak Center for Health and Wellness

    Garfield Heights, Ohio

  • Cutting Edge Research Groupd

    Oklahoma City, Oklahoma

  • Suburban Research Associates

    Media, Pennsylvania

  • Lincoln Research

    Lincoln, Rhode Island

  • Carolina Clinical Trials, Inc.

    Charleston, South Carolina

  • Clinical Neuroscience Solutions Inc.

    Memphis, Tennessee

  • Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center

    Dallas, Texas

  • R/D Clinical Research, Inc.

    Lake Jackson, Texas

  • Novain Neurociencias Group

    Buenos Aires, Argentina

  • Centro de Neuropsiquiatria

    Buenos Aires, Argentina

  • IPEM-Instituto de Prevención de las Enfermedades Mentales.

    Buenos Aires, Argentina

  • Instituto DAMCI

    Córdoba, Argentina

  • Clinica Privada de Salud Mental Santa Teresa de Avila

    La Plata, Argentina

  • Centro de Psiquiatria Biologica

    Mendoza, Argentina

  • Sanatorio Morra

    Córdoba, Córdoba Province, Argentina

  • Centro de Atencion E Invest. Clinica (CAICI)

    Rosario, Santa Fe Province, Argentina

  • The Lyell McEwin Hospital

    Elizabeth Vale, South Australia, Australia

  • RWF Medic Pty Ltd as Trustee for Farnbach Family Trust at Neurotherapy Victoria

    Malvern, Victoria, Australia

  • The Melbourne Clinic

    Richmond, Victoria, Australia

  • Hollywood Medical Centre

    Fremantle, Western Australia, Australia

  • Psychiatry Dispensary

    Burgas, Bulgaria

  • University Multiprofiled Hospital for Active Treatment "Sveti Georgi"

    Plovdiv, Bulgaria

Showing 40 of 105 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.